Jun 12, 2025
FDA nod for acoltremon: What its approval means for clinicians and patients
Author(s): Sheryl Stevenson Alcon’s announcement of the FDA approval for its acoltremon ophthalmic solution 0.003% (Tryptyr; formerly AR-15512) for the …
Resources
Jun 10, 2025
Press Release PAO Action Week
Press Release Hello, The Macular Degeneration Association is one of the 1,200+ patient advocacy organizations (PAOs) in the United …
Jun 10, 2025
Home OCT a ‘safety net’ for reducing treatment burden in wet AMD
ByAnthony DeFino Fact checked byChristine Klimanskis, ELS Key takeaways: Home OCT may help patients achieve extended dosing intervals through consistent …
Jun 2, 2025
Stop Smoking Now to Protect Your Vision, Experts Warn
Edited by Shrabasti Bhattacharya TOPLINE: Current smokers faced up to 12-fold higher risk for age-related macular degeneration, a threefold higher …
May 27, 2025
Aldeyra Therapeutics hits primary end point in 1 of 2 phase 3 trials for reproxalap
Author(s): Emily Kaiser Maharjan Key Takeaways Aldeyra’s phase 3 trial of reproxalap showed statistical superiority in reducing ocular discomfort compared …
May 26, 2025
Remember and Honor Our Fallen Heroes
“Their sacrifice was the ultimate act of love for their country. May we always remember them.” — Unknown
May 16, 2025
PARTICIPATE IN A MARKET RESEARCH STUDY ON VISUAL IMPAIRMENTS
Exafield US, a healthcare market research company based in the USA, is conducting a study on visual impairments and would …
May 15, 2025
Living with GA: How patients in the US and Western Europe cope
Living with GA: How patients in the US and Western Europe cope Author(s): Lynda Charters Key Takeaways Geographic atrophy significantly …
May 15, 2025
The eSight GO
By: Jeffry Gerson, OD, FAAO- Medical Director for the Macular Degeneration Association When we were at our recent in-person seminar …
May 15, 2025
Valeda® Light Delivery System: The First FDA-Approved Treatment for Dry AMD
By: Jeffry Gerson, OD, FAAO- Medical Director for the Macular Degeneration Association Photobiomodulation (PBM) is a new treatment that was …
May 15, 2025
Your Gut and Your Eyes: How a Healthy Gut Microbiome Can Help Protect Your Vision
by Julie Poteet, OD, MS, CNS, FOWNS If you’re living with macular degeneration, you’ve likely heard about vitamins, antioxidants, and …
May 12, 2025
Q&A: Katherine Talcott, MD, on exploring a potential connection between autoimmune diseases and AMD
May 11, 2025, By Sydney M Crago Katherine Talcott, a retina specialist at Cole Eye Institute at the Cleveland Clinic, presented …
May 11, 2025
Happy Mother’s Day
Wishing all the moms a wonderful day.
May 2, 2025
“The effect of a specific vitamin supplement containing L-methylfolate (Ocufolin forte) in patients with neovascular age-related macular degeneration”
By: Tatjana Josifova a,*, Katarzyna Konieczka b,c, Andreas Sch€otzau d, Josef Flammer b a Eye Clinic Orasis, Department for Medical …
Apr 22, 2025
A Young Man with the Heart of Gold- Running for Rita- Update
Running for Rita update Maxim finished the Half Marathon in …
Apr 22, 2025
Treating dry eye disease may reduce migraine severity
By: Moira Mahoney Fact checked by: Christine Klimanskis, ELS Key takeaways: Treatment with ocular lubricants reduced Headache Impact Test scores …
Apr 17, 2025
One Day Only- Matters of Vision! 2025 Denver-Aurora, CO
Matters of Vision! 2025 Denver-Aurora, CO. The Macular Degeneration Association will host a Free educational program on Saturday, May 10th. …
Apr 17, 2025
Vantage Biosciences doses first patient in phase 2 study of VX-01, oral therapy for nonproliferative diabetic retinopathy
Author(s): Martin David Harp Key Takeaways Vantage Biosciences has begun a phase 2 trial for VX-01, targeting moderate to severe …
Apr 6, 2025
Long-Term Visual Outcomes of Patients With nAMD Treated With Anti-VEGF Therapy Lost to Follow-Up
This is interesting and important. The bottom line: If you are getting treated for wet AMD and stop going to …
Mar 31, 2025
The Aira App: On Demand Expert Assistance
With the Aira app, people with vision loss connect to vetted, live, expertly trained assistants. Using the camera on your …
Mar 26, 2025
Researchers develop eye drops that slow progressive vision loss in mice
March 24, 2025 By Jordana Joy, Associate Editor Researchers developed eye drop formulations 17-mer and H105A, both containing a short peptide, …
Mar 24, 2025
Beyond Food: The Mediterranean Diet as a Holistic Approach to AMD Management
Join Our FREE Webinar! Topic: Beyond Food: The Mediterranean Diet as a Holistic Approach to AMD Management When: March 26, …
Mar 24, 2025
Retinal vein occlusion (RVO) patients to participate in a paid market research study
Opinions Link Research is looking for retinal vein occlusion (RVO) patients to participate in a paid market research …
Mar 24, 2025
Bausch + Lomb publishes study results on early patient-reported outcomes with Miebo in patients with DED
March 20, 2025, By Jordana Joy, Associate Editor Patients reported that Miebo significantly reduced overall symptoms severity at the primary endpoint …
Mar 18, 2025
Astaxanthin (AstaReal®) Improved Acute and Chronic Digital Eye Strain in Children: A Randomized Double‑Blind Placebo‑Controlled Trial
New Research Astaxanthin (AstaReal®) Improved Acute and Chronic Digital Eye Strain inChildren: A Randomized Double‑Blind Placebo‑Controlled Trial Karen A. Hecht· …
Mar 18, 2025
Cigarette smoking linked to reduced choroidal vascularity
Author(s): Lynda Charters Key Takeaways Cigarette smoking significantly reduces choroidal vascularity, as indicated by a decreased choroidal vascularity index (CVI). …
Mar 14, 2025
Ozempic is making some patients go blind: ‘Will Ozempic survive this? We’ll see’
By Sarah Caesar | Fact-checked by Barbara Bekiesz | Published March 10, 2025 Industry Buzz “[It’s] important to consider gradually tapering patients onto these drugs. Slowly lowering …
Mar 14, 2025
Can Vitamins Help Slow Down Macular Degeneration?
Macular degeneration is a progressive eye condition that has no cure. In some cases, a specific combination of nutrients found …
Mar 11, 2025
The human impact of geographic atrophy
Author(s): Ophthalmology Times Staff Reports Fact checked by: Sheryl Stevenson Key Takeaways GA significantly impacts patients’ independence, with many reducing …
Mar 10, 2025
Adverum Biotechnologies initiates phase 3 ARTEMIS trial evaluating ixoberogene soroparvovec (Ixo-vec) in patients with wet AMD
Author(s): Martin David Harp Ixo-vec utilizes a proprietary vector capsid, AAV.7m8, carrying an aflibercept coding sequence under the control of …